Type B Adverse Drug Reactions Reported by an Immunoallergology Department

Overview

Journal Pharm Pract (Granada)

Date 2018 Apr 6

PMID 29619134

Citations 2

Authors

Maria J Costa

Maria T Herdeiro

Jorge J Polonia

Ines Ribeiro-Vaz

Carmen Botelho

Eunice Castro

Josefina Cernadas

Affiliations

Soon will be listed here.

Abstract

Objective: Characterization of the adverse drug reactions (ADR) reported by the immunoallergology department (IAD), Centro Hospitalar de São João (Porto), to the Northern Pharmacovigilance Centre (NPC).

Methods: An observational, descriptive and retrospective study was conducted, based in a spontaneous report system. Participants were all the patients from the IAD, with suspected ADR, reported to NPC by specialists after the study was completed.

Results: Studied population had a median age of 41 years, with the predominance of the female gender (73.2%). Allergic rhinitis and asthma were the most frequent comorbidities. All studied ADR were type B, 89.6% were serious, 86.4% unexpected and 2.6% associated with drugs that presented less than 2 years in the market. The most represented drug classes were the non-steroidal anti-inflammatory drugs (NSAIDs) (52.6%) and antibiotics (25.2%). Skin symptoms represented 61.2% of the reported complaints. About 52.9% of these ADR occurred in less than one hour after intake. The most frequent ADR treatment at the time of the reaction was drug interruption (86.2%), followed by the prescription of anti-histamines (42.2%).

Conclusions: Reported ADR to NPC by the Drug Alert Unit were mainly serious, unexpected, associated with NSAIDs and antibiotics and related with marketing authorization medicines older than two years. These results could be very useful to develop strategies to prevent the clinical and economic consequences of ADR.

Citing Articles

Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey.

Srisuriyachanchai W, Cox A, Kampichit S, Jarernsiripornkul N Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834422 PMC: 9959449. DOI: 10.3390/ijerph20043725.

Antibiotic allergy as a cause of hospitalization in adults: a hospital-based study in Ukraine.

Horodnycha O, Zimenkovsky A Pharm Pract (Granada). 2021; 19(1):2055.

PMID: 33520036 PMC: 7819703. DOI: 10.18549/PharmPract.2021.1.2055.

References

Kongkaew C, Noyce P, Ashcroft D . Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008; 42(7):1017-25. DOI: 10.1345/aph.1L037. View

Davies E, Green C, Taylor S, Williamson P, Mottram D, Pirmohamed M . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4(2):e4439. PMC: 2635959. DOI: 10.1371/journal.pone.0004439. View

Wu T, Jen M, Bottle A, Molokhia M, Aylin P, Bell D . Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009. J R Soc Med. 2010; 103(6):239-50. PMC: 2878823. DOI: 10.1258/jrsm.2010.100113. View

Khan D, Solensky R . Drug allergy. J Allergy Clin Immunol. 2010; 125(2 Suppl 2):S126-37. DOI: 10.1016/j.jaci.2009.10.028. View

Bousquet P, Demoly P, Romano A, Aberer W, Bircher A, Blanca M . Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy. 2009; 64(2):194-203. DOI: 10.1111/j.1398-9995.2008.01944.x. View

JOHANSSON S, Hourihane J, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T . A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56(9):813-24. DOI: 10.1034/j.1398-9995.2001.t01-1-00001.x. View

Alexopoulou A, Dourakis S, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M . Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med. 2008; 19(7):505-10. DOI: 10.1016/j.ejim.2007.06.030. View

Dona I, Blanca-Lopez N, Cornejo-Garcia J . NSAIDs are the most frequent medicaments involved in hypersensitivity drug reactions. Eur Ann Allergy Clin Immunol. 2014; 46(1):63. View

Bate A, Evans S . Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009; 18(6):427-36. DOI: 10.1002/pds.1742. View

10.

Polimeni G, Salvo F, Cutroneo P, Morreale I, Caputi A . Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional database. Drug Saf. 2006; 29(5):449-59. DOI: 10.2165/00002018-200629050-00006. View

11.

Cornejo-Garcia J, Blanca-Lopez N, Dona I, Andreu I, Agundez J, Carballo M . Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab. 2010; 10(9):971-80. DOI: 10.2174/138920009790711841. View

12.

Buccellato E, Melis M, Biagi C, Donati M, Motola D, Vaccheri A . Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals. PLoS One. 2015; 10(9):e0139097. PMC: 4584004. DOI: 10.1371/journal.pone.0139097. View

13.

Mirakian R, Ewan P, Durham S, Youlten L, Dugue P, Friedmann P . BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009; 39(1):43-61. DOI: 10.1111/j.1365-2222.2008.03155.x. View

14.

Nogueira Guerra L, Herdeiro M, Ribeiro-Vaz I, Clerigo M, Rocha C, Araujo A . Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System. Expert Opin Drug Saf. 2015; 14(12):1805-13. DOI: 10.1517/14740338.2015.1105214. View

15.

Bouvy J, De Bruin M, Koopmanschap M . Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015; 38(5):437-53. PMC: 4412588. DOI: 10.1007/s40264-015-0281-0. View

16.

Rebelo Gomes E, Fonseca J, Araujo L, Demoly P . Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2007; 38(1):191-8. DOI: 10.1111/j.1365-2222.2007.02870.x. View

17.

Hunziker T, Bruppacher R, Kuenzi U, Maibach R, Braunschweig S, Halter F . Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974-1993. Pharmacoepidemiol Drug Saf. 2002; 11(2):159-63. DOI: 10.1002/pds.669. View

18.

Thong B, Tan T . Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011; 71(5):684-700. PMC: 3093074. DOI: 10.1111/j.1365-2125.2010.03774.x. View

19.

Demoly P, Adkinson N, Brockow K, Castells M, Chiriac A, Greenberger P . International Consensus on drug allergy. Allergy. 2014; 69(4):420-37. DOI: 10.1111/all.12350. View

20.

Green C, Mottram D, Rowe P, Pirmohamed M . Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther. 2000; 25(5):355-61. DOI: 10.1046/j.1365-2710.2000.00298.x. View